Robert Duggan
Clearwater, Florida
Drop Out, University of California, Santa Barbara | Drop Out, University of California, Los Angeles
United States
8
pharmaceuticals, Self Made
$1,900,000,000
1281
#1281 Billionaires 2019
#264 Forbes 400 2016
Robert Duggan is a serial entrepreneur who sold his biotech firm Pharmacyclics to AbbVie in 2015, netting $3.5 billion in pretax cash and stock.The success of Pharmacyclics' cancer drug Imbruvica made him a billionaire in 2013. Duggan, whose son died from brain cancer, became passionate about Pharmacyclic's cancer fighting drugs and first invested in 2004. His enthusiasm for investing began four decades earlier in a corporate finance class he took at University of California at Santa Barbara.Duggan now sits on the board of Pulse Biosciences, of which he is the largest individual shareholder.
Duggan is apparently a top donor to the Church of Scientology, of which he is a member; he says he's given the church nearly $360 million over his lifetime.Duggan enjoys surfing in his spare time.
75
8
Add a review